Local Institution - 0160

Tokyo 1358550

0 studies enrolling now · 1 studies all time

What they study most

Stage IV or Recurrent Non-Small Cell Lung Cancer

Studies at this site

• An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) — Completed